1. Safety assessment of Superba™ krill powder: Subchronic toxicity study in rats
- Author
-
Kjetil Berge, Lena Burri, and Bruce Robertson
- Subjects
No-observed-adverse-effect level ,Krill ,ANCOVA, analysis of covariance ,Health, Toxicology and Mutagenesis ,NOAEL, no observed adverse effect level ,DHA, docosahexaenoic acid ,Toxicology ,Article ,chemistry.chemical_compound ,Animal science ,Astaxanthin ,lcsh:RA1190-1270 ,Omega-3 fatty acids ,SO, soya bean oil ,ANOVA, analysis of variance ,lcsh:Toxicology. Poisons ,Heart weight ,biology ,Toxicity ,Protein ,KP, krill powder ,EPA, eicosapentaenoic acid ,biology.organism_classification ,Subchronic toxicity ,chemistry ,Analysis of variance ,Hepatic dysfunction - Abstract
The safety of krill powder was assessed in a subchronic 13-week toxicity study where rats were fed krill powder or control diets. The krill powder inclusion in the test diet was 9.67% (w/w). There were no differences noted in body weight or food consumption in either gender. Differences in clinical chemistry values were noted in the krill powder-treated animals, but these findings were of no toxicological significance. A significant decrease in absolute heart weight, but not relative heart weight, was observed in both sexes given krill powder, although no corresponding histological changes were observed. Hepatocyte vacuolation was noted histologically in males fed krill powder. This finding was not associated with other indications of hepatic dysfunction. The no observed adverse effect level (NOAEL) for the conditions of this study was considered to be 9.67% krill powder.
- Published
- 2015